@article{351c56b8e8da4c2c92f0110157d4ec1a,
title = "Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2",
abstract = "Fanconi anaemia is an inherited chromosomal instability disorder characterised by cellular sensitivity to DNA interstrand crosslinkers, bone-marrow failure and a high risk of cancer. Eleven FA genes have been identified, one of which, FANCD1, is the breast cancer susceptibility gene BRCA2. At least eight FA proteins form a nuclear core complex required for monoubiquitination of FANCD2. The BRCA2/FANCD1 protein is connected to the FA pathway by interactions with the FANCG and FANCD2 proteins, both of which co-localise with the RAD51 recombinase, which is regulated by BRCA2. These connections raise the question of whether any of the FANC proteins of the core complex might also participate in other complexes involved in homologous recombination repair. We therefore tested known FA proteins for direct interaction with RAD51 and its paralogs XRCC2 and XRCC3. FANCG was found to interact with XRCC3, and this interaction was disrupted by the FA-G patient derived mutation L71P. FANCG was co-immunoprecipitated with both XRCC3 and BRCA2 from extracts of human and hamster cells. The FANCG-XRCC3 and FANCG-BRCA2 interactions did not require the presence of other FA proteins from the core complex, suggesting that FANCG also participates in a DNA repair complex that is downstream and independent of FANCD2 monoubiquitination. Additionally, XRCC3 and BRCA2 proteins co-precipitate in both human and hamster cells and this interaction requires FANCG. The FANCG protein contains multiple tetratricopeptide repeat motifs (TPRs), which function as scaffolds to mediate protein-protein interactions. Mutation of one or more of these motifs disrupted all of the known interactions of FANCG. We propose that FANCG, in addition to stabilising the FA core complex, may have a role in building multiprotein complexes that facilitate homologous recombination repair.",
keywords = "BRCA2, FANCG, Fanconi anaemia, Homologous recombination, TPR motifs, XRCC3",
author = "Shobbir Hussain and Wilson, {James B.} and Eric Blom and Thompson, {Larry H.} and Patrick Sung and Gordon, {Susan M.} and Kupfer, {Gary M.} and Hans Joenje and Mathew, {Christopher G.} and Jones, {Nigel J.}",
note = "Funding Information: The cellular phenotype of FA is characterised by chromosomal instability and hypersensitivity to DNA interstrand crosslinking agents such as mitomycin C (MMC), which suggests a role for the FA proteins in DNA repair, possibly in homologous recombination. This idea is supported by the identity of FANCD1 as BRCA2 [12] , by the connections of BRCA2 with the rest of the FA pathway via interaction with the FANCG, FANCD2 and FANCE proteins [13–15] , and by the co-localisation of FANCG and FANCD2 with RAD51 in DNA damage-induced nuclear foci [13,14,16] . Further support for the involvement of FA proteins in homologous recombination repair comes from evidence that chicken DT40 cells that lack FANCG or FANCC are either severely or mildly defective respectively in repairing chromosomal double-strand breaks (DSBs) by homologous recombination [17,18] , and that disruption of FA genes in mice by gene targeting results in aberrant pairing of homologous chromosomes in the pachytene stage of meiosis [19,20] . Whilst FA-D2 cells (PD20) were reported to show uncompromised recombination repair of I-SceI-induced DNA double strand breaks [21] , conflicting studies show that FA-A, FA-D2 and FA-G patient-derived cells and a FANCA-null mouse embryonic cell line have a moderate defect in HR-mediated repair of DSBs, and are deficient in DSB repair by single-strand annealing [22,23] . Funding Information: SH was supported by a studentship from the Medical Research Council, UK, the Fanconi Anaemia Research Fund, the Daniel Ayling Fanconi Anaemia Trust and FABUK. JBW was funded by a grant from the North West Cancer Research Fund to NJJ (NWCRF-CR624). LHT was funded by the DOE Low-Dose Program and NCI/NIH grant CA89405 for work done under the auspices of the U.S. Department of Energy by the University of California, Lawrence Livermore National Laboratory under Contract No. W-7405-Eng-48. GK was supported by NIH R01 HL063776.",
year = "2006",
month = may,
day = "10",
doi = "10.1016/j.dnarep.2006.02.007",
language = "English (US)",
volume = "5",
pages = "629--640",
journal = "DNA Repair",
issn = "1568-7864",
publisher = "Elsevier B.V.",
number = "5",
}